Skip to main content
Log in

Correlation of radiation treatment interruptions with psychiatric disease and performance status in head and neck cancer patients

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

The purpose of this study is to identify factors predictive of treatment interruptions during radiation therapy (RT) for head and neck cancer.

Methods and materials

The medical records of 280 consecutive patients who completed a 6- or 7-week course of RT for squamous cell carcinoma of the head and neck were reviewed. The number of missed treatment days, excluding those due to holidays or machine downtime, was determined for each patient. All patients were treated to a median dose of 63 Gy (range, 60 to 70 Gy).

Results

The proportion of patients who missed 0, 3–5, 6–10, and greater than 10 days was 25, 59, 12, and 5 %, respectively. The percentage of patients who missed greater than 5 days was 62 % among the 39 patients with Karnofsky Performance Status (KPS) score of 70 or less compared to 10 % among those with a KPS score of greater than 70 (p < 0.01). Among the 33 patients identified with a preexisting psychiatric condition, the percentage that subsequently missed greater than 5 days of treatment was 48 % compared to 13 % among those without a psychiatric condition. When missed RT days were analyzed as a continuous variable, the correlations with both KPS and preexisting psychiatric condition remained highly significant (p < 0.01, for both).

Conclusion

Poor performance status and preexisting psychiatric condition predicted for treatment interruptions during RT for head and neck cancer. In view of the possible detrimental effect on treatment outcome, appropriate social programs should be initiated to overcome potential barriers to RT for these particular populations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Robertson AG, Robertson C, Perone C et al (1998) Effect of gap length and position on results of treatment of cancer of the larynx in Scotland by radiotherapy: a linear quadratic analysis. Radiother Oncol 48:165–173

    Article  PubMed  CAS  Google Scholar 

  2. Groome PA, O’Sullivan B, Mackillop WJ et al (2006) Compromised local control due to treatment interruptions and late treatment breaks in early glottic cancer: population-based outcomes study supporting need for intensified treatment schedules. Int J Radiat Oncol Biol Phys 64:1002–1012

    Article  PubMed  Google Scholar 

  3. Suwinski R, Sowa A, Rutkowski T et al (2003) Time factor in postoperative radiotherapy: a multivariate locoregional control analysis in 868 patients. Int J Radiat Oncol Biol Phys 56:399–412

    Article  PubMed  Google Scholar 

  4. Robertson C, Robertson AG, Hendry JH et al (1998) Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centers. Int J Radiat Oncol Biol Phys 40:319–329

    Article  PubMed  CAS  Google Scholar 

  5. Fesinmeyer MD, Mehta V, Blough D et al (2010) Effect of radiotherapy interruptions on survival in medicare enrollees with local and regional head-and-neck cancer. Int J Radiat Oncol Biol Phys 78:675–681

    Article  PubMed  Google Scholar 

  6. Badiee J, Riggs PK, Rooney AS et al (2012) Approaches to identifying appropriate medication adherence assessments for HIV infected individuals with comorbid bipolar disorder. AIDS Patient Care STDS 26:388–394

    PubMed  Google Scholar 

  7. Gentil L, Vasiliadis HM, Preville M et al (2012) Association between depressive and anxiety disorders and adherence to antihypertensive medication in community-living elderly adults. J Am Geriatr Soc 60:2297–2301

    Article  PubMed  Google Scholar 

  8. Therneau TM, Atkinson EJ (1997) An introduction to recursive partitioning using the RPART routines. Mayo Foundation, Rochester, MN, pp 13–14

    Google Scholar 

  9. Withers HR, Taylor JMG, Maciejewski B (1988) The hazard of accelerated tumour clonogen repopulation during radiotherapy. Acta Oncol 27:131–146

    Article  PubMed  CAS  Google Scholar 

  10. Hendry JH (1992) Treatment acceleration in radiotherapy: the relative time factors and dose–response slopes for tumors and normal tissues. Radiother Oncol 25:308–312

    Article  PubMed  CAS  Google Scholar 

  11. Peters LJ, Withers HR (1997) Applying radiobiological principles to combined modality treatment of head and neck cancer—the time factor. Int J Radiat Oncol Biol Phys 39:831–836

    Article  PubMed  CAS  Google Scholar 

  12. Pajak TF, Laramore GE, Marcial VA et al (1991) Elapsed treatment days—a critical item for radiotherapy quality control review in head and neck trials: RTOG report. Int J Radiat Oncol Biol Phys 20(1):13–20

    Article  PubMed  CAS  Google Scholar 

  13. Fu KK, Pajak TF, Trotti A et al (2000) A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48:7–16

    Article  PubMed  CAS  Google Scholar 

  14. Siddoqio F, Pajak TF, Watkins-Bruner D et al (2008) Pretreatment quality of life predicts for locoregional control in head and neck cancer patients: a radiation therapy oncology group analysis. Int J Radiat Oncol Biol Phys 70:353–360

    Article  Google Scholar 

  15. Karvonen-Gutierrez CA, Ronis DL, Fowler KE et al (2008) Quality of life scores predict survival among patients with head and neck cancer. J Clin Oncol 26:2754–2760

    Article  PubMed  Google Scholar 

  16. Jeremic B, Milicic B (2009) Pretreatment prognostic factors of survival in patients with locally advanced nonmetastatic squamous cell carcinoma of the head and neck treated with radiation therapy with or without concurrent chemotherapy. Am J Clin Oncol 32:163–168

    Article  PubMed  Google Scholar 

  17. De Leeuw JR, De Graeff A, Ros WJ et al (2000) Negative and positive influences of social support on depression in patients with head and neck cancer: a prospective study. Psychooncology 9:20–28

    Article  PubMed  Google Scholar 

  18. Lazure KE, Lydiatt WM, Denman D et al (2008) Association between depression and survival or disease recurrence in patients with head and neck cancer enrolled in a depression prevention trial. Head Neck 31:888–892

    Article  Google Scholar 

  19. Westin T, Jansson Z, Zenckert C et al (1988) Mental depression is associated with malnutrition in patients with head and neck cancer. Arch Otolaryngol head Neck Surg 14:1449–1453

    Article  Google Scholar 

  20. Konski AA, Pajak TF, Movsas B et al (2006) Disadvantage of men living alone participating in Radiation Therapy Oncology Group head and neck trials. J Clin Oncol 24:4177–4183

    Article  PubMed  Google Scholar 

  21. Kugaya A, Akechi T, Okuyama T et al (2000) Prevalence, predictive factors, and screening for psychologic distress in patients with newly diagnosed head and neck cancer. Cancer 88:2817–2823

    Article  PubMed  CAS  Google Scholar 

  22. Katz MR, Kopek N, Waldron J et al (2004) Screening for depression in head and neck cancer. Psychooncology 13:269–280

    Article  PubMed  Google Scholar 

  23. McCaffrey JC, Weitzner M, Kamboukas D et al (2007) Alcoholism, depression, and abnormal cognition in head and neck cancer: a pilot study. Otolaryngol Head Neck Surg 136:92–97

    Article  PubMed  Google Scholar 

  24. DiMatteo MR, Lepper HS, Croghan TW (2000) Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 160:2101–2107

    Article  PubMed  CAS  Google Scholar 

  25. Jenkins C, Carmody TJ, Rush AJ (1998) Depression in radiation oncology patients: a preliminary evaluation. J Affect Disord 50:17–21

    Article  PubMed  CAS  Google Scholar 

  26. Roscoe JA, Kaufman ME, Matteson-Rusby SE et al (2007) Cancer-related fatigue and sleep disorders. Oncologist 12:35–42

    Article  PubMed  Google Scholar 

  27. Pasik SD, Dugan W, McDonald MV et al (1998) Oncologists’ recognition of depression in their patients with cancer. J Clin Oncol 16:1594–1600

    Google Scholar 

  28. Patel U, Thakkar K, Holloway N (2008) Patient compliance to radiation for advanced head and neck cancer at a tertiary care county hospital. Laryngoscope 118:428–432

    Article  PubMed  Google Scholar 

  29. Bese NS, Hendry J, Jeremic B (2007) Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation. Int J Radiat Oncol Biol Phys 68:654–661

    Article  PubMed  Google Scholar 

  30. James ND, Williams MV, Summers ET et al (2008) The management of interruptions to radiotherapy in head and neck cancer: an audit of the effectiveness of national guidelines. Clin Oncol 20:599–605

    Article  CAS  Google Scholar 

  31. Macia I, Garau M, Sole Monne J et al (2009) Compliance to the prescribed overall treatment time (OTT) of curative radiotherapy in normal clinical practice and impact on treatment duration of counteracting short interruptions by treating patients on Saturdays. Clin Transl Oncol 11:302–311

    Article  Google Scholar 

Download references

Conflict of interest

The authors indicate no potential conflict of interest or financial disclosures. The presented research was unfunded. All authors have full control of all primary data and agree to allow the journal to review their data if requested.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Allen M. Chen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sreeraman, R., Vijayakumar, S. & Chen, A.M. Correlation of radiation treatment interruptions with psychiatric disease and performance status in head and neck cancer patients. Support Care Cancer 21, 3301–3306 (2013). https://doi.org/10.1007/s00520-013-1907-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-013-1907-3

Keywords

Navigation